Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Pulmonary Hypertension Diagnostic Network in Belgium: Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension

NCT06405126 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT06405126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06405126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Pulmonary Hypertension Diagnostic Network in Belgium: Validation of a Machine Learning Predictive Model to Distinguish Post-capillary Pulmonary Hypertension
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Unknown status
Start date
February 21, 2024
Completion date
February 28, 2026
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hfpef - heart failure with preserved ejection fraction, pulmonary arterial hypertension, pulmonary hypertension